LACK OF REACTIVATION OF TUBERCULOSIS IN 12,319 PATIENTS WITH PSORIASIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS TREATED wail SECUKINUMAB: AN AD HOC ANALYSIS OF POOLED SAFETY DATA FROM 28 CLINICAL TRIALS

被引：0
|
作者：
Soriano, Enrique R. [1 ]
Elewski, Boni [2 ]
Baddley, John [2 ]
Deodhar, Atul [3 ]
Magrey, Marina [4 ]
Rich, Phoebe [5 ]
Soung, Jennifer [6 ]
Sharma, Abhishek [7 ]
Bao, Weibin [8 ]
Patekar, Manmath [9 ]
Lebwohl, Mark [10 ]
机构：
[1] Hosp Italiano Buenos Aires, Serv Clin Med, Seec Reumatol, Buenos Aires, DF, Argentina
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Case Western Reserve Univ, Sch Med, MetroHlth Med Ctr, Cleveland, OH 44106 USA
[5] Oregon Dermatol & Res, Portland, OR USA
[6] Southern Calif Dermatol, Santa Ana, SC USA
[7] Novartis Healthcare Pvt Ltd, Hyderabad, India
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Novartis Pharma AG, Basel, Switzerland
[10] Icahn Sch Med Mt Sinai, Kimberly & Eric J Waldman Dept Dermatol, New York, NY 10029 USA
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2020年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
77
引用
收藏
页码：65 / 66
页数：2
相关论文
共 31 条
  • [1] Lack of tuberculosis reactivation in 12,319 patients with psoriasis, psoriatic arthritis, or ankylosing spondylitis treated with secukinumab: An ad hoc analysis of pooled safety data from 28 clinical trials
    Elewski, Boni
    Baddley, John W.
    Deodhar, Atul
    Magrey, Marina
    Rich, Phoebe
    Soriano, Enrique
    Soung, Jennifer
    Bao, Weibin
    Patekar, Manmath
    Lebwohl, Mark
    Sharma, Abhishek
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB33 - AB33
  • [2] Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials
    Schreiber, Stefan
    Colombel, Jean-Frederic
    Feagan, Brian G.
    Reich, Kristian
    Deodhar, Atul A.
    McInnes, Iain B.
    Porter, Brian
    Das Gupta, Ayan
    Pricop, Luminita
    Fox, Todd
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (04) : 473 - 479
  • [3] INCIDENCE OF INFLAMMATORY BOWEL DISEASE IN PATIENTS TREATED WITH SECUKINUMAB: POOLED ANALYSIS OF 21 RANDOMISED CONTROLLED PHASE 3/ 4 CLINICAL TRIALS OF PSORIASIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS
    Schreiber, Stefan
    Colombel, Jean-Frederic
    Feagan, Brian G.
    Reich, Kristian
    Deodhar, Atul
    McInnes, Iain B.
    Porter, Brian
    Das Gupta, Ayan
    Pricop, Luminita
    Fox, Todd
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 18 - 18
  • [4] Safety of Secukinumab in Patients with Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis and Hidradenitis Suppurativa: Updated Pooled Data from 69 Clinical Trials
    Deodhar, Atul
    McInnes, Iain
    Baraliakos, Xenofon
    Gottlieb, Alice
    Kiltz, Uta
    Schreiber, Stefan
    Sahoo, Braja Gopal
    Bao, Weibin
    Gaillez, Corine
    Bustamante, Mercedes
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3018 - 3020
  • [5] Secukinumab Demonstrates a Consistent Safety Profile in Patients with Psoriasis, Psoriatic Arthritis and Axial Spondyloarthritis: Updated Pooled Safety Analysis from Clinical Trials
    Deodhar, Atul
    McInnes, Iain
    Baraliakos, Xenofon
    Gottlieb, Alice B.
    Kiltz, Uta
    Schreiber, Stefan
    Sahoo, Braja Gopal
    Bao, Weibin
    Richards, Hanno
    Pricop, Luminita
    Gaillez, Corine
    Dong, Victor
    Mease, Philip J.
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2830 - 2831
  • [6] PATIENT CLUSTERS IDENTIFIED BY MACHINE LEARNING: DATA FROM A POOLED ANALYSIS OF PHASE-3 TRIALS OF SECUKINUMAB IN PSORIATIC ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS WITH AXIAL MANIFESTATIONS
    Baraliakos, X.
    Pournara, E.
    Gladman, D. D.
    Mease, P. J.
    Jahandideh, S.
    Coates, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 879 - 879
  • [7] Presence of psoriatic arthritis has no impact on the clinical efficacy and safety of secukinumab in patients with psoriasis: Pooled analysis of four phase 3 clinical trials
    Gottlieb, Alice B.
    Armstrong, April W.
    Elewski, Boni Elizabeth
    Merola, Joseph F.
    Gomez, Braulio
    Meng, Xiangyi
    Marfo, Kwaku
    Lebwohl, Mark
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB148 - AB148
  • [8] SECUKINUMAB SAFETY AND TOLERABILITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND PSORIASIS: RESULTS FROM A POOLED SAFETY ANALYSIS OF SEVEN INTERNATIONAL PHASE 3 TRIALS
    Soriano, Enrique
    Gottlieb, Alice
    McInnes, Ian B.
    Mease, Philip
    Mpofu, Shephard
    Widmer, Albert
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2016, 22 (03) : 140 - 140
  • [9] Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
    A. Deodhar
    P. J. Mease
    I. B. McInnes
    X. Baraliakos
    K. Reich
    A. Blauvelt
    C. Leonardi
    B. Porter
    A. Das Gupta
    A. Widmer
    L. Pricop
    T. Fox
    Arthritis Research & Therapy, 21
  • [10] Presence of psoriatic arthritis has no impact on the clinical efficacy and safety of secukinumab in patients with psoriasis: Pooled analysis of the phase 3 CLEAR and CLARITY trials
    Bagel, Jerry
    Blauvelt, Andrew
    Tyring, Stephen
    Patekar, Manmath
    Meng, Xiangyi
    Lebwohl, Mark
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB69 - AB69
1234